Source-grounded facts extracted from LivaNova PLC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
LivaNova PLC reported the quarter ended March 31, 2026 results: revenue $362.3 million, EPS $0.40. Guidance raised.
“First-quarter revenue of $362.3 million increased 14.3% on a reported basis and 11.1% on a constant-currency basis as compared to the prior-year period • First-quarter U.S. GAAP diluted earnings per share of $0.40 and adjusted diluted earnings per share of $0.98”
Susan Podlogar was appointed as Director at LivaNova PLC.
“On October 8, 2024, the Board of Directors (the “Board”) of LivaNova PLC (the “Company”) appointed Susan Podlogar to the Board and as a member of the Compensation and Human Capital Management Committee of the Board.”
Trui Hebbelinck departed as Chief Human Resources Officer at LivaNova PLC.
“On September 10, 2024, LivaNova PLC (the “Company”) announced that Trui Hebbelinck, the Company’s Chief Human Resources Officer, will leave her position on September 30, 2024 and commence a period of garden leave.”
LivaNova PLC reported first quarter 2024 results: EPS First-quarter U.S. GAAP diluted loss per share was $0.78 and adjusted diluted earnings per share was $0.73.
“First-quarter U.S. GAAP diluted loss per share was $0.78 and adjusted diluted earnings per share was $0.73”
LivaNova PLC reported quarter ended March 31, 2024 results: revenue $294.9 million. Guidance raised.
“quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance. Financial Summary and Highlights (1) • First-quarter revenue of $294.9 million increased 12.0% on a reported basis and 12.4% on a constant-currency basis, as compared to the prior-year period. Excluding the impact of the Advanced Circulatory Support (ACS)”
LivaNova PLC incurred convertible notes of $345 million with Citibank, N.A. at 2.50% per year maturing March 15, 2029.
“On March 8, 2024, LivaNova PLC (“LivaNova”) issued $345 million aggregate principal amount of its 2.50% convertible senior notes due 2029 (the “Notes”), including $45 million aggregate principal amount issued pursuant to the exercise in full of the initial purchasers’ option to purchase additional Notes.”
LivaNova PLC entered into Indenture with Citibank, N.A., as trustee valued at $345 million aggregate principal amount (effective 2024-03-08).
“On March 8, 2024, LivaNova PLC (“LivaNova”) issued $345 million aggregate principal amount of its 2.50% convertible senior notes due 2029 (the “Notes”), including $45 million aggregate principal amount issued pursuant to the exercise in full of the initial purchasers’ option to purchase additional Notes. The Notes were issued pursuant to an indenture, dated as of March 8 , 2024 (the “Indenture”), between LivaNova and Citibank, N.A., as trustee.”
LivaNova PLC reported quarter and full year ended December 31, 2023 results: revenue $310.1 million, EPS $0.30. Guidance initiated.
“Financial Summary and Highlights 1 • Fourth-quarter revenue of $310.1 million increased 12.8 percent on a reported basis and 11.9 percent on a constant-currency basis, as compared to the prior-year period • Fourth-quarter U.S.”
William A. Kozy changed role as Interim Chief Executive Officer at LivaNova PLC.
“William A. Kozy will step down from his current position as Interim Chief Executive Officer of the Company on March 1, 2024 but will remain the Chair of the Board.”
Vladimir A. Makatsaria was appointed as Director at LivaNova PLC.
“In addition, Mr. Makatsaria was appointed as a member of the Board as of the Effective Date.”
Vladimir A. Makatsaria was appointed as Chief Executive Officer at LivaNova PLC.
“the Company’s Board of Directors (the “Board”) appointed Vladimir A. Makatsaria as Chief Executive Officer of the Company, effective as of March 1, 2024”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.